Physician profile
Cindy Hung
NPI 1023221132
$3,525.91
in general payments reported to CMS, 2019-2025
9 companies · $1,857 in 2025
The $1,857 reported for 2025 was more than what 92% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $88.62 · 2021: $124 · 2022: $72.22 · 2023: $407 · 2024: $587 · 2025: $1,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,739 · Travel and Lodging: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,739.04 |
| Travel and Lodging | $1,111.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,539.77 | 2019-2025 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $816.21 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $544.37 | 2019-2025 | Clareon, Precision7, Dailies Total1 |
| Bausch & Lomb Americas INC. | $270.86 | 2024 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $231.14 | 2019-2020 | |
| Allergan, INC. | $48.13 | 2022 | |
| Rxsight INC | $28.29 | 2025 | Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Oyster Point Pharma, INC. | $24.09 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.